NWBO replaces expiring S-3 shelf to maintain registration status
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Northwest Biotherapeutics (NWBO) reported that it filed a new Form S-3 shelf registration on October 23, 2025 to replace its existing shelf. Shelf registrations expire three years from effectiveness; the company’s current shelf became effective on October 25, 2022 and therefore expires on October 25, 2025. Filing the new shelf before expiration maintains an ongoing effective registration framework.
The company’s common stock trades on the OTCQB under the symbol NWBO.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
FAQ
What did NWBO disclose in this 8-K?
NWBO filed a new Form S-3 shelf registration on October 23, 2025 to replace its expiring shelf.
Why did Northwest Biotherapeutics (NWBO) file a new S-3 now?
Shelf registrations expire after three years; the existing shelf went effective on October 25, 2022 and expires on October 25, 2025.
What is the status of NWBO’s existing shelf registration?
It went effective on October 25, 2022 and expires on October 25, 2025.
What is the trading market and symbol for NWBO?
NWBO’s common stock trades on the OTCQB under the symbol NWBO.
What is the purpose stated for the new S-3 filing by NWBO?
To maintain an ongoing effective shelf registration by filing before the current shelf’s expiration.